GENE ONLINE|News &
Opinion
Blog

Gene Therapy
CRISPR Therapeutics Scores Prestigious Grant for Advancing Gene Therapies for HIV
2020-12-16
uniQure’s Gene Therapy Impresses in Pivotal Trial Raising Hopes of a Hemophilia B Cure
2020-11-22
CRISPR/Cas9 Gene Editing in Cell and Gene Therapies
2020-11-08
Novartis Expands Foothold in Gene Therapy With New Acquisition
2020-10-30
Is Bayer’s Entry to the Gene Therapy Market Worth it’s Investment?
2020-10-27
Harvard Spinout Bags $1.8 Billion Worth Gene Therapy Deal with Roche
2020-10-15
Pfizer, Sangamo Dose First Hemophilia A Patient in Phase 3 with Gene Therapy Candidate
2020-10-08
FDA Rejects BioMarin Pharmaceuticals’ Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A
2020-08-20
Spotlight: New Gene Therapies on the Horizon for the Treatment of Neurogenetic Diseases
2020-08-03
Novartis Enters $75 Million Collaboration with Sangamo for its Zinc Finger Gene Editing Technology
2020-08-01
A Rising Hope in Therapeutics — From Precision Medicine to Advanced Therapies
2020-07-19
Takeda, Carmine Ink $900 Million Pact for Non-Viral Gene Therapy
2020-07-05
BIO Digital 2020 Highlights: Challenges in Bringing New Cell and Gene Therapies to Market
2020-06-23
Successful Gene-Editing to Reverse Deafness Scores Another Win for Gene Therapy
2020-06-07
Daiichi Sankyo Invests in Ultragenyx’s Technology to Bolster Gene Therapy Pipeline
2020-04-02
1 6 7 8 9
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top